These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9789710)

  • 41. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic and pharmacodynamic responses to chronic administration of the selective serotonin reuptake inhibitor citalopram in rats.
    Wikell C; Apelqvist G; Carlsson B; Hjorth S; Bergqvist PB; Kugelberg FC; Ahlner J; Bengtsson F
    Clin Neuropharmacol; 1999; 22(6):327-36. PubMed ID: 10626092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study of the ameliorating effects of an enteral nutrient for liver failure on hepatic encephalopathy: effects of SF-1008C on plasma and brain free amino acids, intracerebral amine concentrations and electroencephalogram in portacaval shunted rats with ammonia loading].
    Kido Y; Sugiyama K; Nakao S; Kashiyama E; Suda T; Miyamoto G; Shimizu T; Shintani S; Kohri H
    Nihon Yakurigaku Zasshi; 1986 Jul; 88(1):47-56. PubMed ID: 3093339
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
    Li SX; Perry KW; Wong DT
    Neuropharmacology; 2002 Feb; 42(2):181-90. PubMed ID: 11804614
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Monoamines and metabolites in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy.
    Bergeron M; Reader TA; Layrargues GP; Butterworth RF
    Neurochem Res; 1989 Sep; 14(9):853-9. PubMed ID: 2480534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The antidepressant venlafaxine may act as a neurodevelopmental toxicant in cuttlefish (Sepia officinalis).
    Bidel F; Di Poi C; Budzinski H; Pardon P; Callewaert W; Arini A; Basu N; Dickel L; Bellanger C; Jozet-Alves C
    Neurotoxicology; 2016 Jul; 55():142-153. PubMed ID: 27283470
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Venlafaxine metabolism as a marker of cytochrome P450 enzyme 2D6 metabolizer status.
    Nichols AI; Lobello K; Guico-Pabia CJ; Paul J; Preskorn SH
    J Clin Psychopharmacol; 2009 Aug; 29(4):383-6. PubMed ID: 19593180
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
    [TBL] [Abstract][Full Text] [Related]  

  • 49. S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
    Millan MJ; Gobert A; Lejeune F; Newman-Tancredi A; Rivet JM; Auclair A; Peglion JL
    J Pharmacol Exp Ther; 2001 Aug; 298(2):565-80. PubMed ID: 11454918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta).
    Fontenot MB; Musso MW; McFatter RM; Anderson GM
    J Am Assoc Lab Anim Sci; 2009 Mar; 48(2):176-84. PubMed ID: 19383215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic drug monitoring of racemic venlafaxine and its main metabolites in an everyday clinical setting.
    Reis M; Lundmark J; Björk H; Bengtsson F
    Ther Drug Monit; 2002 Aug; 24(4):545-53. PubMed ID: 12142641
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in high K+-evoked serotonin release and serotonin 2A/2C receptor binding in the frontal cortex of rats with thioacetamide-induced hepatic encephalopathy.
    Kaneko K; Kurumaji A; Watanabe A; Yamada S; Toru M
    J Neural Transm (Vienna); 1998; 105(1):13-30. PubMed ID: 9588757
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of the oral administration of branched chain amino acids on hepatic encephalopathy in the rat.
    Beaubernard C; Delorme ML; Opolon P; Boschat M; Morin J; Oryszcyn MP; Franco D
    Hepatology; 1984; 4(2):288-94. PubMed ID: 6200419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
    Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
    Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated brain 5-hydroxytryptophol levels in experimental portal-systemic encephalopathy.
    Bergqvist PB; Some M; Apelqvist G; Helander A; Bengtsson F
    Pharmacol Toxicol; 1997 Apr; 80(4):187-90. PubMed ID: 9140138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sustained citalopram treatment in experimental hepatic encephalopathy: effects on entrainment to the light-dark cycle and melatonin.
    Kugelberg FC; Apelqvist G; Carlsson B; Ahlner J; Bengtsson F
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):80-8. PubMed ID: 16867175
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Portacaval shunt in the rat: selective alterations in behavior and brain serotonin.
    Bengtsson F; Nobin A; Falck B; Gage FH; Jeppsson B
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1611-6. PubMed ID: 2426719
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain quinolinic acid in chronic experimental hepatic encephalopathy: effects of an exogenous ammonium acetate challenge.
    Bergqvist PB; Heyes MP; Bugge M; Bengtsson F
    J Neurochem; 1995 Nov; 65(5):2235-40. PubMed ID: 7595512
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats.
    Perry KW; Fuller RW
    J Neural Transm (Vienna); 1997; 104(8-9):953-66. PubMed ID: 9451727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.